Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.
about
Cell death and DAMPs in acute pancreatitisSterile inflammatory response in acute pancreatitisInflammasomes in pancreatic physiology and diseaseEthyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesTargeting HMGB1 in inflammationAssociation between high mobility group box‑1 protein expression and cell death in acute pancreatitisAnti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia/reperfusion.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation.High-mobility group box 1 released from astrocytes promotes the proliferation of cultured neural stem/progenitor cells.DAMPening inflammation by modulating TLR signalling.Combination of allopurinol and hyperbaric oxygen therapy: a new treatment in experimental acute necrotizing pancreatitis?HMGB1 contributes to kidney ischemia reperfusion injury.HMGB1 in health and disease.High-mobility group box 1 protein and its role in severe acute pancreatitis.TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis.Redox signaling in acute pancreatitis.Glycyrrhizin suppresses the expressions of HMGB1 and relieves the severity of traumatic pancreatitis in rats.TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.Spatial and temporal differences of HMGB1 expression in the pancreas of rats with acute pancreatitisHMGB1 is a therapeutic target for sterile inflammation and infection.TLR4-mediated NF-κB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis.Scolopendra subspinipes mutilans protected the cerulein-induced acute pancreatitis by inhibiting high-mobility group box protein-1.Bench-to-bedside review: High-mobility group box 1 and critical illness.Therapeutic potential of HMGB1-targeting agents in sepsis.Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.Relationship between vascular reactivity and expression of HMGB1 in a rat model of septic aorta.Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats.HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway.Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice.The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?Cutaneous lupus erythematosus: recent lessons from animal models.Role of Apoptosis in Amplifying Inflammatory Responses in Lung DiseasesSterile inflammation in the liver and pancreas.The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.High-mobility group box-1 in sterile inflammation.Immune-modulating therapy in acute pancreatitis: fact or fiction.Circulating nucleosomes as predictive markers of severe acute pancreatitis.Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis.
P2860
Q26994999-1AC88D3B-EC10-4120-A941-0E96C46EF518Q27023854-74778262-FB0F-4167-BC42-2BA862AB16BDQ27027483-2BD87EB8-6C8D-421B-BEFA-AFCBE9707054Q28068263-A901DD79-7F19-4996-AEB5-C00E61FE8FE5Q28266138-91A29C26-D394-47D0-9065-6393C22CE86FQ33702146-2719CF6F-54E2-4E62-87D9-48061D65AA11Q33769729-8FDA3B74-3129-4693-882C-ECE56EBC1708Q33814903-19FA1EF0-8947-4C4C-8182-6D8EBB91D775Q33836853-9230E802-2563-4311-896A-C1C683C49033Q33999811-A6640788-8760-4D9E-93A0-33B433C9E94CQ34000360-0575A3EF-E459-459E-8DC6-EE971A4723BAQ34035570-F283E4B3-52B6-4E98-BDAA-6915C88E8D1DQ34225221-CC3E97B0-9285-42B6-A187-AB067AC07534Q34457038-8E7D18E1-8CC0-4932-87D9-78FDE4A86B55Q34622835-25608EE7-828F-434A-A847-980E871596CFQ35045701-68A87CDC-A967-41B1-A3E0-B7BE6A4B5FA2Q35085962-E3D30490-5E8A-4804-B7D6-B2F8116D3A5EQ35178638-15844D5B-0708-45A9-85A9-A43B98CF2A7AQ35534222-16AE1F81-93EF-42BF-AC16-E984111885A4Q35865242-E4C488E3-62E8-44E3-9D6D-A8BC837E7087Q35919201-8DC2D10E-3602-4047-8E11-6FC687894148Q35953553-A0520287-A590-4B31-9A56-AFBB93663FECQ36393999-3F43BCA2-437F-4EF9-82A0-43110E2B8252Q36699188-4DA5714C-EC19-4B02-8536-D87A0902DEADQ36954659-D0132B1D-B249-4B2F-9968-68158B429067Q36981872-8FA374AC-6AD2-48DE-BEB7-BF651C126613Q37225236-04E2CC2C-CD5F-4AE5-80D8-5C883962B649Q37300315-33391AA7-0025-43E7-93EF-12ED951E0957Q37316911-C50C3EB9-AD90-4C97-8AAC-1550C7D10D0DQ37573376-93DAC4AF-BB48-4E4B-B877-936B57B68851Q37662678-1E2B4FA8-E13A-4070-AD84-30B6F3A1F30CQ37772786-70DBA71E-9770-451F-BE2E-4483CB47B37BQ37778643-BB0EF8D2-6F44-4E66-A247-049154BF649CQ37955890-6F19BC20-7DC5-4963-9450-CC8F65C47B6CQ38121573-0D5ED4BB-00CE-4CB6-82BB-4B56ED94D112Q38209945-76B1A906-3DFF-4E46-812B-CFC6097C0F0BQ38220792-1796EBB8-5EFD-47CC-9F52-7B5498FDCD26Q38266870-CBFC4217-5BE0-48BC-B662-944668F280DFQ38542886-067E7501-1790-4F26-BB1B-CA97EDC5BD6BQ38654274-6E5CE5C8-36AF-4D0E-B694-A192B5C6AB58
P2860
Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@ast
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@en
type
label
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@ast
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@en
prefLabel
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@ast
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@en
P2093
P2860
P356
P1476
Blockade of high mobility grou ...... tal severe acute pancreatitis.
@en
P2093
Hidehiro Sawa
Makoto Shinzeki
Takahiro Nakajima
Takashi Ueda
Takeo Yasuda
Yoshifumi Takeyama
Yoshikazu Kuroda
P2860
P304
P356
10.3748/WJG.V12.I47.7666
P407
P577
2006-12-01T00:00:00Z